Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
9.97
-0.01 (-0.10%)
Feb 3, 2026, 4:00 PM EST - Market closed
Delcath Systems Employees
Delcath Systems had 96 employees as of December 31, 2024. The number of employees increased by 20 or 26.32% compared to the previous year.
Employees
96
Change (1Y)
20
Growth (1Y)
26.32%
Revenue / Employee
$829,198
Profits / Employee
$12,479
Market Cap
345.96M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 96 | 20 | 26.32% |
| Dec 31, 2023 | 76 | 24 | 46.15% |
| Dec 31, 2022 | 52 | -3 | -5.45% |
| Dec 31, 2021 | 55 | 19 | 52.78% |
| Dec 31, 2020 | 36 | 3 | 9.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Viemed Healthcare | 1,380 |
| Cerus | 630 |
| OrthoPediatrics | 562 |
| RxSight | 498 |
| Quanterix | 471 |
| Sight Sciences | 216 |
| Profound Medical | 142 |
| Perspective Therapeutics | 140 |
DCTH News
- 7 days ago - Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Business Wire
- 13 days ago - Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 21 days ago - Delcath Systems: Stabilizing Fundamentals Justify A Rating Upgrade - Seeking Alpha
- 25 days ago - Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 4 weeks ago - Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma - Business Wire
- 2 months ago - Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma - Business Wire
- 2 months ago - Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program - Business Wire
- 2 months ago - Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma - Business Wire